
Evexia Lifecare Ltd. (EVEXIA) Lifecare 52 Week High Streak: Second Straight Session
Updated: 15 Oct 2026 • 9:32 am
Posted by:

Evexia Lifecare 52 Week High Streak has now extended for its second straight session, with the stock trading within 2% of its one-year peak across both days. According to latest Univest data, the cumulative move across the streak is 2.25%, while the stock touched Rs 2.27 and was last trading at Rs 2.27. The latest Univest data confirms the price pattern, but it does not establish a company-specific catalyst for the continued move.
At 15 October 2026 at 9:22 AM IST, EVEXIA was trading above the previous close of Rs 2.24, after opening at Rs 2.22 and moving between Rs 2.22 and Rs 2.27. The company’s market capitalisation stood at Rs 492.41 crore. For readers, the repeated-high pattern is more useful than a one-day move because it shows the stock has stayed close to its yearly high across sessions, which keeps the focus on whether the range can persist.
Evexia Lifecare 52 Week High Streak: Consecutive High Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2.27 |
| Previous Close | Rs 2.24 |
| Today's Move | +Rs 0.03 (+1.34%) |
| Open | Rs 2.22 |
| High | Rs 2.27 |
| Low | Rs 2.22 |
| Market Capitalisation | Rs 492.41 crore |
Evexia Lifecare Ltd. (EVEXIA) traded at Rs 2.27 versus the previous close of Rs 2.24, a rise of 1.34%. The stock opened at Rs 2.22, reached a high of Rs 2.27 and touched a low of Rs 2.22.
Evexia Lifecare share price today shows a small but clear intraday advance, with the stock last trading at Rs 2.27 versus the previous close of Rs 2.24. That is a gain of Rs 0.03, or 1.34%, and it places the stock at the day’s high of Rs 2.27. The open was Rs 2.22, while the low was also Rs 2.22, so the early range was compact and the price stayed near the top of that band through the available session update.
For the market-cap view, Evexia Lifecare stands at Rs 492.41 crore, which keeps EVEXIA firmly in the small absolute-price segment even as the streak draws attention. The important point for a reader is that the present move is not being framed by a single sharp jump; instead, the stock has remained close to its 52-week high for two sessions in a row. That makes the EVEXIA share price more relevant as a short-run tracking point than as an isolated one-day print.
In practical terms, this also means Evexia Lifecare stock news is now being read through a streak lens. The stock has been trading near its yearly high rather than making a one-off appearance there, and that is the pattern investors are watching in the EVEXIA NSE and EVEXIA BSE listings. The latest update shows continuity in price behaviour, not a confirmed company announcement driving the move.
What the Repeated 52-Week Highs Show
Evexia Lifecare 52 Week High Streak matters because repeated proximity to the one-year peak often changes how the market reads the stock. Here, the key fact is simple: EVEXIA has stayed within 2% of its 52-week high for a second straight session, and the cumulative streak move of 2.25% gives the pattern a broader context than a single session can provide. The latest reading shows consistency in where the stock is trading, even though it does not tell us why the move has persisted.
That distinction matters. A one-day move can be noisy, but back-to-back highs or near-high prints show that the stock is being watched over more than one trading day. The current pattern also places Evexia Lifecare in the broader bucket of stocks hitting 52 week highs and stocks at one year high today, where the central question is whether the market continues to accept prices in this zone. The latest Univest figures confirm the pattern, but they do not identify a fresh catalyst.
For EVEXIA, the streak angle is especially relevant because the company’s share price is still low in absolute terms, which can make percentage moves look large even when the rupee change is small. The repeated-high structure, however, is the more meaningful point for analysis. It signals that the stock has not drifted away from its yearly peak after the first touch, and that keeps the EVEXIA share price update in focus for traders and long-term watchers alike.
Evexia Lifecare Ltd. (EVEXIA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 492.41 crore |
| P/E Ratio | 309.37x |
| P/B Ratio | 0.87x |
| ROE | 0.15% |
| ROCE | 0.16% |
| EPS | Rs 0.01 |
| Book Value Per Share | Rs 2.58 |
| Dividend Yield | 0% |
Evexia Lifecare Ltd. (EVEXIA) fundamental metrics show P/E 309.37x, P/B 0.87x, ROE 0.15%, ROCE 0.16%. These figures provide context only and are not a buy or sell signal.
Evexia Lifecare Ltd. has a market capitalisation of Rs 492.41 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 309.37x, P/B at 0.87x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 0.15% and ROCE of 0.16%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.01, book value per share of Rs 2.58, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 13.35x, median ROE of 4.09%, median ROCE of 6.04%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Trading |
| Industry | Trading |
| Benchmark Scope | same industry |
| Company P/E Ratio | 309.37x |
| Benchmark Median P/E | 13.35x |
| Benchmark Average P/E | 60.2x |
| Benchmark P/E Range | 0x to 2,813.48x |
| Company P/B Ratio | 0.87x |
| Benchmark Median P/B | 1.33x |
| Company ROE | 0.15% |
| Benchmark Median ROE | 4.09% |
| Company ROCE | 0.16% |
| Benchmark Median ROCE | 6.04% |
| Company Market Capitalisation | Rs 492.41 crore |
| Benchmark Median Market Cap | Rs 52.86 crore |
Evexia Lifecare Ltd. (EVEXIA) is classified under sector: Trading and industry: Trading.
Evexia Lifecare Ltd. (EVEXIA) has a P/E ratio of 309.37x, which is above the benchmark median of 13.35x, a difference of +2,217.38%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Evexia Lifecare Ltd. (EVEXIA) has a ROE of 0.15%, which is below the benchmark median of 4.09%, a difference of -96.33%. Evexia Lifecare Ltd. (EVEXIA) has a ROCE of 0.16%, which is below the benchmark median of 6.04%, a difference of -97.35%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Manbro Industries Ltd. | KDGREEN | 492.43 | 119.78 | 7.01 | 12.44 | 12.23 |
| Bijoy Hans Ltd. | ARVAYA | 494.14 | 0 | 8.65 | 3.93 | 5.74 |
| Transchem Ltd. | TRANSCHEM | 509.55 | 75.78 | 5.86 | 5.27 | 6.89 |
| GP Eco Solutions India Ltd. | GPECO | 512.58 | 12.74 | 4.66 | 49.12 | 38.98 |
| Riddhi Siddhi Gluco Biols Ltd. | RIDDHI | 516.02 | 0 | 0.33 | 4.09 | 4.99 |
Evexia Lifecare Ltd. (EVEXIA) has a P/E ratio of 309.37x compared with the displayed peer median of 12.74x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 0.15% compares with a peer median of 5.27% across the companies shown in the table. ROCE stood at 0.16% versus the displayed peer median of 6.89%, providing a capital-efficiency comparison. Evexia Lifecare Ltd. (EVEXIA) has a market capitalisation of Rs 492.41 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Evexia Lifecare
- Evexia Lifecare 52 Week High Streak has extended to a second straight session, keeping the stock on watch for repeated near-high trading.
- The cumulative move across the streak is 2.25%, which gives the pattern a broader reading than a single-day print.
- EVEXIA last traded at Rs 2.27 versus the previous close of Rs 2.24, keeping the EVEXIA share price update in focus.
- The company’s P/E ratio of 309.37 stands far above the Trading sector median, making Evexia Lifecare stock analysis more complex.
- The stock’s market capitalisation of Rs 492.41 crore places it among the more closely watched names in the Trading sector.
About Evexia Lifecare Ltd.
Evexia Lifecare Ltd. is listed in the Trading sector and Trading industry, with a market capitalisation of Rs 492.41 crore. The company’s latest valuation snapshot shows a P/E ratio of 309.37, a P/B ratio of 0.87, ROE of 0.15%, ROCE of 0.16%, EPS of 0.01 and book value of Rs 2.58. Its dividend yield is 0.
For investors scanning Evexia Lifecare company news, the current interest is less about a company announcement and more about how the share price has stayed near the 52-week high. That is why EVEXIA continues to appear in stock news and market update searches.
EVEXIA is listed on both NSE and BSE, and its current move is being tracked mainly through the lens of price behaviour, valuation and sector comparison.
Frequently Asked Questions
What does Evexia Lifecare 52 Week High Streak mean?
It means Evexia Lifecare has traded within 2% of its 52-week high for consecutive sessions. In this case, the streak is the second straight session, which keeps the stock on watch for repeated near-high trading.
How many sessions has EVEXIA stayed near its one-year high?
EVEXIA has stayed near its one-year high for two consecutive trading sessions. The latest Univest figures show that the stock remains within 2% of its 52-week peak across both sessions.
What is the cumulative move across the streak?
The cumulative move across the current streak is 2.25%. That figure is more useful than the one-day change because it measures the full multi-session price movement.
Did Evexia Lifecare make a new 52-week high today?
The data confirms that the stock traded near its 52-week high, but it does not state that a new one-year high was made today. The key point is the repeated proximity to that level.
How is Evexia Lifecare trading today?
Evexia Lifecare was last trading at Rs 2.27, up Rs 0.03 or 1.34% from the previous close of Rs 2.24. The stock moved between Rs 2.22 and Rs 2.27 in the session update.
Is Evexia Lifecare expensive compared with its sector?
On earnings multiples, the stock looks higher-valued. Its P/E ratio of 309.37 is far above the Trading sector median of 13.35, though its P/B ratio of 0.87 sits below the sector median.
What should investors monitor next in Evexia Lifecare stock news?
Investors should watch whether the stock continues to trade near its yearly high, how the next price update behaves versus the current range, and whether any company-specific development emerges to explain the streak.
Why is the Evexia Lifecare share price being tracked closely?
Because the stock has held near its 52-week high for a second straight session. That repeated pattern makes the EVEXIA share price relevant for readers following stocks at one year high today and related market update searches.
Track Evexia Lifecare Ltd. (EVEXIA) Share Price on Univest
Use Evexia Lifecare Ltd. (EVEXIA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Recent Articles

TD Power Shares Jump 5% as Sensex and Nifty Rally Ahead of Q2 Results on 12 November: The 350% Three-Year Run, the Recent Slide and What the Q1 Base Says
11 November 2026

Balrampur Chini Share Price Up Over 50% in a Year: the Balrampur Chini PLA Plant at Rs 3,100 Crore, Q2 Profit of Rs 102 Crore, the Rs 4 Dividend and What Is Not Confirmed
11 November 2026

Nvidia Shares Crash to a 7-Month Low: Why Jensen Huang Wealth Fell by About $10 Billion, What the Board Probe Covers and What Is Not Proven
11 November 2026

Stocks to Watch on 11 November 2026: Cochin Shipyard Profit Halves, MRF Q2 Profit Falls 27%, Data Patterns, IRB Toll Revenue and Four More Stocks in News
11 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
TD Power Shares Jump 5% as Sensex and Nifty Rally Ahead of Q2 Results on 12 November: The 350% Three-Year Run, the Recent Slide and What the Q1 Base Says
Balrampur Chini Share Price Up Over 50% in a Year: the Balrampur Chini PLA Plant at Rs 3,100 Crore, Q2 Profit of Rs 102 Crore, the Rs 4 Dividend and What Is Not Confirmed
Nvidia Shares Crash to a 7-Month Low: Why Jensen Huang Wealth Fell by About $10 Billion, What the Board Probe Covers and What Is Not Proven
Stocks to Watch on 11 November 2026: Cochin Shipyard Profit Halves, MRF Q2 Profit Falls 27%, Data Patterns, IRB Toll Revenue and Four More Stocks in News
Dividend Stocks Alert for 11 November 2026: Last Day to Buy 13 Stocks Before the 12 November Record Date, the Full List With Dividend Amounts and Yields

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





